Late-Stage Cancer Patients: Psychological and Physical Quality of Life

2009 ◽  
Author(s):  
Heidi F. Christianson ◽  
Jo M. Weis ◽  
Nadya A. Fouad
2013 ◽  
Vol 31 (3) ◽  
pp. 266-281 ◽  
Author(s):  
Heidi Fowell Christianson ◽  
Jo M. Weis ◽  
Nadya A. Fouad

2013 ◽  
Vol 11 (4) ◽  
pp. 165-173 ◽  
Author(s):  
Andrea Croom ◽  
Heidi Hamann ◽  
Siobhan Kehoe ◽  
Elizabeth Paulk ◽  
Deborah Wiebe

2021 ◽  
pp. 162-168
Author(s):  
Marianne Davies

Lung cancer is the leading cause of cancer-related deaths worldwide. Most patients are diagnosed with late-stage disease. Ninety percent of lung cancer cases can be attributed to tobacco smoking. Smoking cessation efforts have led to reductions in cancer-related deaths. Early screening can help to diagnose patients at earlier stages with improved outcomes. Lung cancer patients suffer the highest symptom burden and psychological distress above other cancers. Symptom burden is due to late-stage disease and treatment side effects. Psychological distress, anxiety, and depression are influenced by internal and external stigma. These lead to the negative impact on quality of life for lung cancer patients as well as family caregivers. Lung cancer–specific tools have been developed to assist in the screening and identification of distress, stigma, and quality-of-life metrics for lung cancer patients. Several organizations have formed to support the educational and psychological needs of lung cancer patients. Early assessment of symptom and psychological distress and integration of palliative care services can improve the quality of life of patients with lung cancer.


2018 ◽  
Vol 4 (Supplement 2) ◽  
pp. 101s-101s
Author(s):  
J.G. Doss ◽  
W.M.N. Ghani ◽  
I.A. Razak ◽  
Y.H. Yang ◽  
S.N. Rogers ◽  
...  

Background: Standard outcome disease parameters like tumor control, overall survival and complications are now complemented with health-related quality of life (HRQoL) data as an important source of information concerning the impacts of disease and treatment outcomes for head and neck cancer patients. Aim: This study aims to assess changes in oral cancer patients' HRQoL and the impact of disease stage on HRQoL scores from the point of diagnosis (pretreatment) through the one, three and six month follow-ups. Differences in characteristics between patients presenting early and late were also explored. Methods: HRQoL data were collected from seven hospital-based centers using the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N) V4.0. A total of 300 patients were recruited. Independent sample t-test, χ2 and paired sample t-test were used to analyze data. The Statistical Package for Social Sciences (SPSS) version 12.0 was used, whereby P < 0.05 was considered to be statistically significant. Results: Mean age was 61.0 ± 13.7 years old with most of them being females (60.7%) and of Indian ethnicity (35.0%). Betel quid chewing was the most common risk habit practiced (48.2%). The most common subsite was tongue and floor of mouth (42.6%). Surgical intervention (41.1%) was the most common treatment. Significant differences in ethnicity and treatment modality were observed between early and late stage patients. Among late stage patients, attrition rate increased significantly with increasing age, with higher proportions of attrition at later follow-ups. At pretreatment, HRQoL scores were significantly lower for late than early stage patients. At one month posttreatment, GF, H&N domains and FACT-H&N (TOI) summary scores showed significant deterioration among both early and late stage patients. In contrast, emotional domain showed significant improvement for early and late stage patients at 1, 3 and six month posttreatment. Although HRQoL deterioration was still observed among early and late stage patients at six months posttreatment, it did not achieve statistical significance. Conclusion: Advanced disease is associated with poorer HRQoL. Domains most commonly affected were the functional, physical and head and neck concerns. Although ethnic differences were observed across different disease stages, its influence on patients' HRQoL was not evident in this study.


Sign in / Sign up

Export Citation Format

Share Document